145 related articles for article (PubMed ID: 37455357)
1. Succinic semialdehyde dehydrogenase deficiency in mice and in humans: An untargeted metabolomics perspective.
Peters TMA; Engelke UFH; de Boer S; Reintjes JTG; Roullet JB; Broekman S; de Vrieze E; van Wijk E; Wamelink MMC; Artuch R; Barić I; Merx J; Boltje TJ; Martens J; Willemsen MAAP; Verbeek MM; Wevers RA; Gibson KM; Coene KLM
J Inherit Metab Dis; 2024 May; 47(3):417-430. PubMed ID: 37455357
[TBL] [Abstract][Full Text] [Related]
2. Correlation of blood biomarkers with age informs pathomechanisms in succinic semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.
Jansen EE; Vogel KR; Salomons GS; Pearl PL; Roullet JB; Gibson KM
J Inherit Metab Dis; 2016 Nov; 39(6):795-800. PubMed ID: 27686230
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular outcomes from the 5-Year natural history study of SSADH Deficiency, a model metabolic neurodevelopmental disorder.
Tokatly Latzer I; Roullet JB; Afshar-Saber W; Lee HHC; Bertoldi M; McGinty GE; DiBacco ML; Arning E; Tsuboyama M; Rotenberg A; Opladen T; Jeltsch K; García-Cazorla À; Juliá-Palacios N; Gibson KM; Sahin M; Pearl PL
J Neurodev Disord; 2024 Apr; 16(1):21. PubMed ID: 38658850
[TBL] [Abstract][Full Text] [Related]
4. Enzyme Replacement Therapy for Succinic Semialdehyde Dehydrogenase Deficiency: Relevance in γ-Aminobutyric Acid Plasticity.
Lee HHC; Pearl PL; Rotenberg A
J Child Neurol; 2021 Nov; 36(13-14):1200-1209. PubMed ID: 33624531
[TBL] [Abstract][Full Text] [Related]
5. Succinic semialdehyde dehydrogenase deficiency (SSADHD): Pathophysiological complexity and multifactorial trait associations in a rare monogenic disorder of GABA metabolism.
Malaspina P; Roullet JB; Pearl PL; Ainslie GR; Vogel KR; Gibson KM
Neurochem Int; 2016 Oct; 99():72-84. PubMed ID: 27311541
[TBL] [Abstract][Full Text] [Related]
6. Temporal metabolomics in dried bloodspots suggests multipathway disruptions in aldh5a1
Brown M; Turgeon C; Rinaldo P; Roullet JB; Gibson KM
Mol Genet Metab; 2019 Dec; 128(4):397-408. PubMed ID: 31699650
[TBL] [Abstract][Full Text] [Related]
7. Understanding the Molecular Mechanisms of Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD): Towards the Development of SSADH-Targeted Medicine.
Lee HHC; McGinty GE; Pearl PL; Rotenberg A
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269750
[TBL] [Abstract][Full Text] [Related]
8. Post-mortem tissue analyses in a patient with succinic semialdehyde dehydrogenase deficiency (SSADHD). I. Metabolomic outcomes.
Kirby T; Walters DC; Brown M; Jansen E; Salomons GS; Turgeon C; Rinaldo P; Arning E; Ashcraft P; Bottiglieri T; Roullet JB; Gibson KM
Metab Brain Dis; 2020 Apr; 35(4):601-614. PubMed ID: 32172518
[TBL] [Abstract][Full Text] [Related]
9. Rett syndrome (MECP2) and succinic semialdehyde dehydrogenase (ALDH5A1) deficiency in a developmentally delayed female.
Brown M; Ashcraft P; Arning E; Bottiglieri T; McClintock W; Giancola F; Lieberman D; Hauser NS; Miller R; Roullet JB; Pearl P; Gibson KM
Mol Genet Genomic Med; 2019 May; 7(5):e629. PubMed ID: 30829465
[TBL] [Abstract][Full Text] [Related]
10. SSADH deficiency in an Italian family: a novel ALDH5A1 gene mutation affecting the succinic semialdehyde substrate binding site.
Leo S; Capo C; Ciminelli BM; Iacovelli F; Menduti G; Funghini S; Donati MA; Falconi M; Rossi L; Malaspina P
Metab Brain Dis; 2017 Oct; 32(5):1383-1388. PubMed ID: 28664505
[TBL] [Abstract][Full Text] [Related]
11. Maternal glutamine supplementation in murine succinic semialdehyde dehydrogenase deficiency, a disorder of γ-aminobutyric acid metabolism.
Brown MN; Walters DC; Schmidt MA; Hill J; McConnell A; Jansen EEW; Salomons GS; Arning E; Bottiglieri T; Gibson KM; Roullet JB
J Inherit Metab Dis; 2019 Sep; 42(5):1030-1039. PubMed ID: 31032972
[TBL] [Abstract][Full Text] [Related]
12. The presence and severity of epilepsy coincide with reduced γ-aminobutyrate and cortical excitatory markers in succinic semialdehyde dehydrogenase deficiency.
Tokatly Latzer I; Bertoldi M; DiBacco ML; Arning E; Tsuboyama M; MacMullin P; Sachee D; Rotenberg A; Lee HHC; Aygun D; Opladen T; Jeltsch K; García-Cazorla À; Roullet JB; Gibson KM; Pearl PL
Epilepsia; 2023 Jun; 64(6):1516-1526. PubMed ID: 36961285
[TBL] [Abstract][Full Text] [Related]
13. Targeted screening of succinic semialdehyde dehydrogenase deficiency (SSADHD) employing an enzymatic assay for γ-hydroxybutyric acid (GHB) in biofluids.
Wernli C; Finochiaro S; Volken C; Andresen-Streichert H; Buettler A; Gygax D; Salomons GS; Jansen EE; Ainslie GR; Vogel KR; Gibson KM
Mol Genet Metab Rep; 2017 Jun; 11():81-89. PubMed ID: 28649510
[TBL] [Abstract][Full Text] [Related]
14. A Missense Variant in
Vernau KM; Struys E; Letko A; Woolard KD; Aguilar M; Brown EA; Cissell DD; Dickinson PJ; Shelton GD; Broome MR; Gibson KM; Pearl PL; König F; Van Winkle TJ; O'Brien D; Roos B; Matiasek K; Jagannathan V; Drögemüller C; Mansour TA; Brown CT; Bannasch DL
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32887425
[TBL] [Abstract][Full Text] [Related]
15. Intestinal Dysbiosis as a component of pathophysiology in succinic semialdehyde dehydrogenase deficiency (SSADHD).
Kirby TO; Shi X; Walters D; Roullet JB; Gibson KM
Mol Genet Metab; 2022 Jan; 135(1):42-46. PubMed ID: 34896003
[TBL] [Abstract][Full Text] [Related]
16. Novel mutations in two unrelated Italian patients with SSADH deficiency.
Balzarini M; Rovelli V; Paci S; Rigoldi M; Sanna G; Pillai S; Asunis M; Parini R; Ciminelli BM; Malaspina P
Metab Brain Dis; 2019 Oct; 34(5):1515-1518. PubMed ID: 31267348
[TBL] [Abstract][Full Text] [Related]
17. Succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism: an update on pharmacological and enzyme-replacement therapeutic strategies.
Vogel KR; Ainslie GR; Walters DC; McConnell A; Dhamne SC; Rotenberg A; Roullet JB; Gibson KM
J Inherit Metab Dis; 2018 Jul; 41(4):699-708. PubMed ID: 29460030
[TBL] [Abstract][Full Text] [Related]
18. Consensus guidelines for the diagnosis and management of succinic semialdehyde dehydrogenase deficiency.
Tokatly Latzer I; Bertoldi M; Blau N; DiBacco ML; Elsea SH; García-Cazorla À; Gibson KM; Gropman AL; Hanson E; Hoffman C; Jeltsch K; Juliá-Palacios N; Knerr I; Lee HHC; Malaspina P; McConnell A; Opladen T; Oppebøen M; Rotenberg A; Walterfang M; Wang-Tso L; Wevers RA; Roullet JB; Pearl PL
Mol Genet Metab; 2024 May; 142(1):108363. PubMed ID: 38452608
[TBL] [Abstract][Full Text] [Related]
19. ALDH5A1-deficient iPSC-derived excitatory and inhibitory neurons display cell type specific alterations.
Afshar-Saber W; Teaney NA; Winden KD; Jumo H; Shi X; McGinty G; Hubbs J; Chen C; Tokatly Latzer I; Gasparoli F; Ebrahimi-Fakhari D; Buttermore ED; Roullet JB; Pearl PL; Sahin M
Neurobiol Dis; 2024 Jan; 190():106386. PubMed ID: 38110041
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic relevance of mTOR inhibition in murine succinate semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.
Vogel KR; Ainslie GR; Jansen EE; Salomons GS; Gibson KM
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):33-42. PubMed ID: 27760377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
